Company profile
LIGAND PHARMACEUTICALS INC insider acquisitions
Company CIK 0000886163 · Reported insider acquisitions and filing context.
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 23, 2026.
| Type / code | Reported security | Transactions | Known purchase value | Missing amounts |
|---|---|---|---|---|
| Exercise / conversionCode M | Common StockNon-derivative · Currency not specified | 1 | Not applicable | 0 |
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
11 dated transactions · 5 of 5 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Oct 2, 2026 | LIGAND PHARMACEUTICALS INCCommon Stock | Reardon Andrew | Exercise / conversion |
| Dec 16, 2025 | LIGAND PHARMACEUTICALS INCCommon Stock | Espinoza Octavio | Exercise / conversion |
| Dec 16, 2025 | LIGAND PHARMACEUTICALS INCCommon Stock | Espinoza Octavio | Exercise / conversion |
| Dec 16, 2025 | LIGAND PHARMACEUTICALS INCCommon Stock | Espinoza Octavio | Exercise / conversion |
| Dec 16, 2025 | LIGAND PHARMACEUTICALS INCCommon Stock | Espinoza Octavio | Exercise / conversion |
| Dec 16, 2025 | LIGAND PHARMACEUTICALS INCCommon Stock | Espinoza Octavio | Exercise / conversion |
| Dec 8, 2025 | LIGAND PHARMACEUTICALS INCCommon Stock | Aryeh Jason | Exercise / conversion |
| Nov 7, 2025 | LIGAND PHARMACEUTICALS INCCommon Stock | Gray Nancy Ryan | Exercise / conversion |
| Nov 7, 2025 | LIGAND PHARMACEUTICALS INCCommon Stock | Gray Nancy Ryan | Exercise / conversion |
| Nov 7, 2025 | LIGAND PHARMACEUTICALS INCCommon Stock | LAMATTINA JOHN L | Exercise / conversion |
| Nov 7, 2025 | LIGAND PHARMACEUTICALS INCCommon Stock | LAMATTINA JOHN L | Exercise / conversion |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Price history is not available
Market-price history is not connected yet.
LGND · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | Reardon AndrewCLO & Secretary | Exercise / conversionCommon StockNon-derivative security · Code M | 340 | 52.27Value: 17,771.8Currency not specified | View ↗ |
| Trade: | Espinoza OctavioChief Financial Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 181 | 103.42Value: 18,719.02Currency not specified | View ↗ |
| Trade: | Espinoza OctavioChief Financial Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 652 | 92.65Value: 60,407.8Currency not specified | View ↗ |
| Trade: | Espinoza OctavioChief Financial Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 285 | 63.62Value: 18,131.7Currency not specified | View ↗ |
| Trade: | Espinoza OctavioChief Financial Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 69 | 57.22Value: 3,948.18Currency not specified | View ↗ |
| Trade: | Espinoza OctavioChief Financial Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 1,194 | 52.84Value: 63,090.96Currency not specified | View ↗ |
| Trade: | Aryeh JasonDirector | Exercise / conversionCommon StockNon-derivative security · Code M | 2,034 | 69.51Value: 141,383.34Currency not specified | View ↗ |
| Trade: | Gray Nancy RyanDirector | Exercise / conversionCommon StockNon-derivative security · Code M | 3,015 | 73.57Value: 221,813.55Currency not specified | View ↗ |
| Trade: | Gray Nancy RyanDirector | Exercise / conversionCommon StockNon-derivative security · Code M | 3,556 | 66.19Value: 235,371.64Currency not specified | View ↗ |
| Trade: | LAMATTINA JOHN LDirector | Exercise / conversionCommon StockNon-derivative security · Code M | 2,034 | 69.51Value: 141,383.34Currency not specified | View ↗ |
| Trade: | LAMATTINA JOHN LDirector | Exercise / conversionCommon StockNon-derivative security · Code M | 2,145 | 66.13Value: 141,848.85Currency not specified | View ↗ |
11 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →